| ||||||||||||||
|
|
|||||||||||||



Departments of *Anaesthesiology and Reanimation,
Biochemistry,
Pharmacology, and
Pathology, Inonu University School of Medicine, Malatya, Turkey
Address correspondence and reprint requests to Mahmut Durmus, MD, Department of Anaesthesiology, Inonu University, School of Medicine, 44069 Malatya, Turkey. Address e-mail to mdurmus{at}inonu.edu.tr
Dexamethasone effectively decreases the incidence of nausea and vomiting among pediatric and adult patients. In this study, we evaluated the effects of single-dose dexamethasone on wound healing in a prospective, randomized, experimental animal model. Anesthesia was induced with thiopental 100 mg/kg intraperitoneally. Dexamethasone 1 mg/kg was administered intraperitoneally in a dexamethasone group, and physiological saline was administered in a control group. Collagenization, epithelization, and fibroblast content were significantly less in the dexamethasone group compared with the control group (P values of 0.002, 0.041, and 0.023, respectively). The vascularity and the degree of inflammatory cells were more intense in the dexamethasone group compared with the control group (P values of 0.023 and 0.002, respectively). The white blood cell count was similar in the control (7.84 ± 2.09) and dexamethasone (6.98 ± 2.12) groups. The mean hydroxyproline level was 0.72 ± 0.13 mg/g in the dexamethasone and 1.03 ± 0.19 mg/g in the control group. Hydroxyproline levels were significantly less in the dexamethasone group (P = 0.001). We conclude that dexamethasone at 1 mg/kg may have negative effects on wound healing.
IMPLICATIONS: We evaluated the effects of dexamethasone on wound healing in a prospective, randomized, experimental animal model. Our results show that dexamethasone at 1 mg/kg may have negative effects on wound healing.
This article has been cited by other articles:
![]() |
C. Czarnetzki, N. Elia, C. Lysakowski, L. Dumont, B. N. Landis, R. Giger, P. Dulguerov, J. Desmeules, and M. R. Tramer Dexamethasone and Risk of Nausea and Vomiting and Postoperative Bleeding After Tonsillectomy in Children: A Randomized Trial JAMA, December 10, 2008; 300(22): 2621 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gercek, O. Yildirim, D. Konya, S. Bozkurt, S. Ozgen, T. Kilic, A. Sav, and N. Pamir Effects of Parenteral Fish-Oil Emulsion (Omegaven) on Cutaneous Wound Healing in Rats Treated With Dexamethasone JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 161 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kim, C. J. Cote, C. Cristoloveanu, A. G. Roth, P. Vornov, M. A. Jennings, J. P. Maddalozzo, and C. Sullivan There Is No Dose-Escalation Response to Dexamethasone (0.0625-1.0 mg/kg) in Pediatric Tonsillectomy or Adenotonsillectomy Patients for Preventing Vomiting, Reducing Pain, Shortening Time to First Liquid Intake, or the Incidence of Voice Change Anesth. Analg., May 1, 2007; 104(5): 1052 - 1058. [Abstract] [Full Text] [PDF] |
||||
|